FLEX February 2024

C.F. Roy et al.

International Journal of Pediatric Otorhinolaryngology 166 (2023) 111469

[21] J.A. Lindeboom, E.J. Kuijper, E.S. Bruijnesteijn van Coppenraet, R. Lindeboom, J. M. Prins, Surgical excision versus antibiotic treatment for nontuberculous mycobacterial cervicofacial lymphadenitis in children: a multicenter, randomized, controlled trial, Clin. Infect. Dis. 44 (8) (Apr 15 2007) 1057 – 1064, https://doi.org/ 10.1086/512675. [22] J. van Ingen, M.J. Boeree, D. van Soolingen, J.W. Mouton, Resistance mechanisms and drug susceptibility testing of nontuberculous mycobacteria, Drug Resist. Updates 15 (3) (Jun 2012) 149 – 161, https://doi.org/10.1016/j.drup.2012.04.001. [23] J. Jarand, A. Levin, L. Zhang, G. Huitt, J.D. Mitchell, C.L. Daley, Clinical and microbiologic outcomes in patients receiving treatment for Mycobacterium

abscessus pulmonary disease, Clin. Infect. Dis. 52 (5) (Mar 1 2011) 565 – 571, https://doi.org/10.1093/cid/ciq237. [24] J.A. Lindeboom, Conservative wait-and-see therapy versus antibiotic treatment for nontuberculous mycobacterial cervicofacial lymphadenitis in children, Clin. Infect. Dis. 52 (2) (Jan 15 2011) 180 – 184, https://doi.org/10.1093/cid/ciq070. [25] Y. Gallois, H. Cogo, C. Debuisson, et al., Nontuberculous lymphadenitis in children: what management strategy? Int. J. Pediatr. Otolaryngol. 122 (Jul 2019) 196 – 202, https://doi.org/10.1016/j.ijporl.2019.04.012.

8

Downloaded for Anonymous User (n/a) at Seattle Children's Hospital from ClinicalKey.com by Elsevier on December 18, 2023. For personal use only. No other uses without permission. Copyright ©2023. Elsevier Inc. All rights reserved.